Help Prevent Itchy Allergy Eyes With LASTACAFT®

When your eyes itch because of eye allergies, lasting relief matters. You can get that with LASTACAFT® ophthalmic solution—a prescription eyedrop that works in only 3 minutes and lasts all day through 16 hours.1-3

If you have eye allergies, talk to your eye doctor about once-daily LASTACAFT®.

Prevent Itchy allergy eyes

 
overlay
overlay
footer

Enter your email address and click the unsubscribe button to remove yourself from our registration list.

We're sorry to see you go.


This field is required.



footer

You have been removed from our registration list and will no longer receive communications from Allergan about LASTACAFT® ophthalmic solution.



overlay
overlay

Coupon Full Terms and Conditions

Patient: You must present this card to the pharmacist along with your prescription to participate in this program. This card is good for up to 50% off the first and second prescription of LASTACAFT® (alcaftadine ophthalmic solution) 0.25%, not to exceed $75 per prescription. The third prescription is covered up to 100%, not to exceed $100. Total savings on all 3 prescriptions not to exceed $250. In addition, you can save up to an extra $5 if you fill your prescription within 7 days of the date it is prescribed. This card must be presented at the time of each fill for instant savings. Offer is only good at participating retailers. For any questions, call the LASTACAFT® Savings Program at 1-855-276-2950.

Eligibility: Offer not valid for patients participating in Medicare, Medicaid, or any similar federal or state healthcare program, including any state medical or pharmaceutical assistance programs. If patients are eligible for drug benefits under any such program, they cannot use this coupon. Offer void where prohibited by law, taxed, or restricted. This promotion cannot be combined with any other programs, offers, or discounts. Offer good only in the United States. Allergan, Inc., reserves the right to rescind, revoke, and amend this offer without notice.

Pharmacist instructions for a patient with an Eligible Third Party: Submit the claim to the primary Third Party Payer first, then submit the balance due to Therapy First Plus as a Secondary Payer COB (coordinator of benefits) with the patient responsibility amount and a valid Other Coverage Code (eg, 8). The patient payment amount will be reduced by 50%, up to $75, on the first and second prescription, and by 100%, up to $100, on the third prescription. Reimbursement will be received from Therapy First Plus.

Pharmacist instructions for a cash-paying patient: Submit this claim to Therapy First Plus. A valid Other Coverage Code (eg, 1) is required. The patient payment amount will be reduced by 50%, up to $75, on the first and second prescription, and by 100%, up to $100, on the third prescription. Reimbursement will be received from Therapy First Plus.

Valid Other Coverage Code required.

For any questions regarding Therapy First Plus online processing, please call the Help Desk at 1-800-422-5604.

Offer expires December 31, 2015. Good for up to 3 prescriptions.

APPROVED USE
LASTACAFT® is a prescription medicine approved for the prevention of itching associated with eye allergies.

IMPORTANT SAFETY INFORMATION
WARNINGS AND PRECAUTIONS
To minimize contaminating the dropper tip of the bottle and solution, do not touch your eyelids or the areas around your eyes with the dropper tip. Keep bottle tightly closed when not in use.

Do not wear a contact lens if your eye is red.

LASTACAFT® should not be used to treat contact lens-related irritation.

Remove contact lenses before putting LASTACAFT® in your eyes. The preservative in LASTACAFT® may be absorbed by soft contact lenses. Lenses may be put back in your eyes 10 minutes after using LASTACAFT®.

LASTACAFT® is for topical use in your eyes only.

SIDE EFFECTS
The most common eye-related side effects that were reported in less than 4% of LASTACAFT® treated eyes were: eye irritation, burning and/or stinging in the eyes after use, eye redness, and eye itching.

The most common non–eye-related side effects that were reported in less than 3% of patients with LASTACAFT® treated eyes were: inflammation of the nose and the upper part of the throat, headache, and the flu. Some of these side effects were similar to the symptoms of eye allergies.

Please click here for the full Prescribing Information.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1080.

overlay
overlay
overlay
overlay

APPROVED USE
LASTACAFT® is a prescription medicine approved for the prevention of itching associated with eye allergies.

IMPORTANT SAFETY INFORMATION
WARNINGS AND PRECAUTIONS
To minimize contaminating the dropper tip of the bottle and solution, do not touch your eyelids or the areas around your eyes with the dropper tip. Keep bottle tightly closed when not in use.

Do not wear a contact lens if your eye is red.

LASTACAFT® should not be used to treat contact lens-related irritation.

Remove contact lenses before putting LASTACAFT® in your eyes. The preservative in LASTACAFT® may be absorbed by soft contact lenses. Lenses may be put back in your eyes 10 minutes after using LASTACAFT®.

LASTACAFT® is for topical use in your eyes only.

SIDE EFFECTS
The most common eye-related side effects that were reported in less than 4% of LASTACAFT® treated eyes were: eye irritation, burning and/or stinging in the eyes after use, eye redness, and eye itching.

The most common non–eye-related side effects that were reported in less than 3% of patients with LASTACAFT® treated eyes were: inflammation of the nose and the upper part of the throat, headache, and the flu. Some of these side effects were similar to the symptoms of eye allergies.

Please click here for the full Prescribing Information.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1080.

References:

1. LASTACAFT® Prescribing Information. 2. Torkildsen G, Shedden A. The safety and efficacy of alcaftadine 0.25% ophthalmic solution for the prevention of itching associated with allergic conjunctivitis. Curr Med Res Opin. 2011;27(3):623-631. 3. Data on file, Allergan, Inc., 2005.

Privacy & Terms    Allergan.com    Site Map    Unsubscribe

©2014 Allergan, Inc., Irvine, CA 92612  ® marks owned by Allergan, Inc.
Adobe and Reader are registered trademarks owned by Adobe Systems Incorporated.
pskw is a trademark owned by PSKW, LLC.  APC10SU14  143704

The information on this site is intended for U.S. residents only. Please visit the Allergan website for your country of residence for information concerning Allergan products and services available there.

itchy itchy itchy itchy